[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fP1my2Kmyk65Pxjx9LSQO5Oy49ryvyNHh924mAE-_lAU":8,"$fOgIi4oggW18QF-eHAtPFEMplShNWfDqb2OfkU9MGAjk":55,"$fR9wntuKsLRtAKVdr4dFi5e7nM731sEMD8KmQ4gtOkKU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},50302,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"吉西他滨与替吉奥：化疗用药安全与细节全解","","https://ystcdn.venuertc.com/venue/AI/f9d7aee7-9cbf-4182-a6b9-57463834127b.jpg","\u003C!-- 胰腺肿瘤化疗用药安全指南 HTML组件输出 -->\n\u003Cdiv class=\"drugguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drugguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">吉西他滨与替吉奥：化疗用药安全与细节全解\u003C/h1>\n  \u003Cdiv class=\"drugguide-intro\">\n    说起来，吉西他滨与替吉奥是治疗实体瘤领域里较为常见的两类化疗药物，尤其在用于手术后的辅助化疗方案中被广泛采纳。这两类药品虽然都属于抗肿瘤药，但在使用方法、潜在风险以及与其他药品的相互作用方面，各有讲究。本文将用7个关键点带你了解用药前必须掌握的操作细节，助你安全高效用药。\n  \u003C/div>\n\n  \u003C!-- 01 剂型特点与成分解读 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-1\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型特点与成分解读 💊\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>吉西他滨（Gemcitabine）：\u003C/strong>属于核苷类似物抗肿瘤药。中国常用为注射用吉西他滨，规格一般为200mg、500mg、1000mg冻干粉针剂。需由专业医护人员静脉点滴给药，口服无效。\u003Cbr>\n      \u003Cstrong>替吉奥（Tegafur, Gimeracil and Oteracil Potassium Capsules，S-1）：\u003C/strong>是一种口服复方抗肿瘤药，胶囊剂型。常规规格为20mg和25mg胶囊，每粒含不同量的三种成分（替加氟、吉美嘧啶、奥替拉西），成分配比固定。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">小贴士\u003C/span> 吉西他滨只适合静脉点滴，不可自行服用或注射。替吉奥务必整粒吞服，不能咬碎或溶解，避免损失药效和刺激口腔。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药理作用机制简述 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-2\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药理作用机制简述 🦠\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>吉西他滨：\u003C/strong>通过抑制核酸合成而阻断癌细胞分裂复制，进而抑制肿瘤生长。吉西他滨进入细胞后，被转化为活性代谢产物，插入到DNA链中，使细胞无法正常进行DNA复制及修复。\u003Cbr>\n      \u003Cstrong>替吉奥：\u003C/strong>其主要成分替加氟为5-氟尿嘧啶（5-FU）前体，其它两个组分则分别抑制5-FU降解、减少胃肠毒性，从而提升疗效并缓解副作用。药物在体内缓慢释放，达到持续杀伤肿瘤细胞的效果。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">理解药理\u003C/span> 两种药物组合能协同杀伤肿瘤细胞，实际用药阶段以实现持续抑制和减少耐药为目标。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 服用/使用方法与注意事项 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-3\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 服用/使用方法与注意事项 ⏰\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>吉西他滨：\u003C/strong>必须在医院静脉注射，每次用药需严格按医生制定的方案施行。常见方案为每周1次，连续2-3周作为一个周期。注射过程中监测生命体征，如有不适立刻告知医务人员。\u003Cbr>\n      \u003Cstrong>替吉奥：\u003C/strong>通常按体表面积每日分2次整粒吞服，建议饭后30分钟内用温水送服。服药时间间隔要尽量均匀——举例，如果早晚各一次，间隔应保持在12小时左右。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">正确做法\u003C/span> 更改剂量或时间前，务必先征询医生；如遇误服、漏服，以专业建议为准处理，不可自行随意补服或停药。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 用药适应与禁忌要点 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-4\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药适应与禁忌要点 🚫\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>适应范围：\u003C/strong>吉西他滨及替吉奥常用于多种实体瘤化疗，在医生指导下联合或单独使用，具体用途应以说明书和规范操作为准。\u003Cbr>\n      \u003Cstrong>禁忌情况：\u003C/strong>\n      \u003Cul>\n        \u003Cli>既往对吉西他滨或替吉奥任一成分有严重过敏史者禁用。\u003C/li>\n        \u003Cli>严重骨髓抑制患者、白细胞或血小板过低不得启用化疗。\u003C/li>\n        \u003Cli>肝肾功能严重不全的患者一般不推荐使用，如特殊情况，需根据医嘱调整用量且严密监控。\u003C/li>\n        \u003Cli>孕妇、哺乳期妇女应避免使用，两者可能产生胚胎毒性或影响乳汁。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">特别提醒\u003C/span> 任何药物过敏史或严重既往病史需提前主动告知医生，避免用药不良事件。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用重点警示 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-5\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用重点警示 ⚠️\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>吉西他滨：\u003C/strong>不建议与其他骨髓抑制性药物（如某些抗生素、免疫抑制剂）并用，否则增加血液毒性风险。如需合用，须加强血常规等指标监测。\u003Cbr>\n      \u003Cstrong>替吉奥：\u003C/strong>禁忌合用黄嘌呤氧化酶抑制剂（如别嘌醇）、亚叶酸、华法林等，可显著增加毒性或药效，严重时威胁生命安全。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">务必遵医嘱\u003C/span> 启动新药物前请报告全部正在服用和曾用药物，含中药、保健品在内。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 特殊人群用药调整 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-6\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群用药调整 👪\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>儿童用药：\u003C/strong>吉西他滨及替吉奥的儿童剂量需严格个体化，不可套用成人标准。临床上通常严格按体表面积或体重换算，建议有儿科肿瘤专科医生指导下才能用药。\u003Cbr>\n      \u003Cstrong>老年患者：\u003C/strong>因肝肾功能或骨髓储备可能较低，初始剂量宜保守并密切监控。\u003Cbr>\n      \u003Cstrong>肝肾功能不全者：\u003C/strong>需调整剂量甚至暂停用药，整个疗程应动态评估肝肾功能。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">案例示例\u003C/span> 临床中曾有一位55千克女性患者，手术后按医嘱接受吉西他滨和替吉奥联合化疗，期间血常规、肝肾功能受到严格监测，有效控制了不良反应。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 常见不良反应与紧急处理 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-7\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应与紧急处理 🛡️\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>常见副作用：\u003C/strong>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>吉西他滨：\u003C/strong>最易发生骨髓抑制（白细胞、血小板减少）、发热、恶心呕吐、轻到中度肝功能异常等。少数人会有皮疹、乏力、水肿。\u003C/li>\n        \u003Cli>\u003Cstrong>替吉奥：\u003C/strong>口腔黏膜炎、轻中度腹泻、厌食、色素沉着、手足发红脱皮是常见反应，部分患者可能出现白细胞减少、皮肤过敏。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>紧急处理：\u003C/strong>\n      \u003Cul>\n        \u003Cli>出现发热、持续乏力、皮下出血点等症状时，应及时复查血常规并向医生反馈。\u003C/li>\n        \u003Cli>如恶心严重无法进食、腹泻不止、皮肤黏膜严重损伤等情况，须尽快就医停药/对症处理。\u003C/li>\n        \u003Cli>大量脱发、指甲变色、手足发麻多为可逆现象，疗程结束后部分可缓解。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">数据参考\u003C/span> 公开研究显示，吉西他滨导致白细胞减少的发生率在25%-40%之间，替吉奥引起消化道副反应不超过20%\u003Cbr>\n        \u003Cspan class=\"drugguide-badge\">严肃提醒\u003C/span> 如合用药品后出现意外反应，切勿自作主张增减药量，应立即与主治医生沟通。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存与药品维护 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-8\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存与药品维护 🗃️\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>吉西他滨：\u003C/strong>原装药品应密封保存于常温、干燥、避光处。配制后如未立即使用，需在2-8℃冷藏，并在医嘱时间内尽快使用完毕，超期不可再用。\u003Cbr>\n      \u003Cstrong>替吉奥：\u003C/strong>请放在阴凉干燥处，避免高温潮湿环境，远离儿童。每次用药后盖紧瓶盖，严禁分装或乱放，避免误服。\u003Cbr>\n      \u003Cdiv class=\"drugguide-tip\">\n        \u003Cspan class=\"drugguide-badge\">过期处理\u003C/span> 过期或变质药品勿自行丢弃，将其交回药房或专业药品回收点统一销毁。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服与过量应对策略 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-9\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量应对策略 ⏳\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cstrong>替吉奥：\u003C/strong>如忘记服用一次，尽快补服，再与原计划时间点间隔至少8小时，切勿一次性双倍补服。\u003Cbr>\n      \u003Cstrong>吉西他滨：\u003C/strong>漏用一剂应联系医生调整日程，不可自行重复给药。\u003Cbr>\n      \u003Cstrong>过量风险：\u003C/strong>若服用剂量超过上限，可能出现严重的白细胞减少、出血、难以控制的反应。此时应尽快送医处理，说明所用药物剂量及时间。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语与安全总结 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-conclu\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语与安全用药再提醒\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      总结来看，吉西他滨、替吉奥各有给药方式与专门的安全措施，只要按方案规范执行，优势在于协同增强疗效，部分副作用可控。\u003Cbr>\n      \u003Cspan class=\"drugguide-badge\">最终提醒\u003C/span> 静脉与口服化疗药都不能随意更改剂量、频率，遇不良反应时需积极反馈，定期复查很重要。用药全程应信赖专科医生和药师指导，保证用药安全和效果最大化。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"drugguide-section drugguide-bg-ref\">\n    \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cul class=\"drugguide-ref-list\">\n      \u003Cli>Heinemann V., Quietzsch D., Gieseler F. et al. (2006). Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>, 24(24), 3946-3952.\u003C/li>\n      \u003Cli>Shirasaka T., Shimamoto Y., Ohshimo H., et al. (1996). Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. \u003Cem>Anticancer Drugs\u003C/em>, 7(5), 548-557.\u003C/li>\n      \u003Cli>Sohal D. P., Kennedy E. B., Khorana A. et al. (2016). Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. \u003Cem>Journal of Clinical Oncology\u003C/em>, 34(23), 2784-2796.\u003C/li>\n      \u003Cli>Saif MW. (2014). S-1: a new oral fluoropyrimidine in gastrointestinal cancers. \u003Cem>Expert Opinion on Investigational Drugs\u003C/em>, 23(9): 1437-1451.\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide-container {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  margin: 0 auto;\n  max-width: 820px;\n  color: #333;\n  background: #fcfcfd;\n  padding: 28px 16px 60px 16px;\n  border-radius: 20px;\n  box-shadow: 0 6px 30px rgba(120,160,180,0.10);\n  box-sizing: border-box;\n}\n.drugguide-title {\n  font-size: 2.2em;\n  margin-bottom: 18px;\n  font-weight: bold;\n  letter-spacing: 1.5px;\n  color: #275281;\n  padding: 8px 0 10px 0;\n  text-align: center;\n  border-left: 8px solid #a4c1ed;\n  background: linear-gradient(90deg, #eef1f9 60%, #e4d9ff 100%);\n  border-radius: 12px;\n}\n.drugguide-intro {\n  font-size: 1.10em;\n  background: #e5eaf5;\n  padding: 16px 18px;\n  border-radius: 14px;\n  margin-bottom: 16px;\n  line-height: 1.7;\n  color: #4d568a;\n  box-shadow: 0 3px 15px rgba(140,180,210,0.08);\n}\n.drugguide-section {\n  margin: 30px 0 36px 0;\n  padding: 0;\n  border-radius: 18px;\n  overflow: hidden;\n}\nh2.drugguide-subtitle {\n  font-size: 1.25em;\n  line-height: 1.35;\n  color: #2d4564;\n  font-weight: bold;\n  margin: 0;\n  padding: 16px 0 12px 28px;\n  border-left: 6px solid #82a6e6;\n  border-radius: 0 10px 10px 0;\n  text-shadow: 0 2px 6px #e8eefa;\n  letter-spacing: 0.5px;\n  background-position: left center;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n.drugguide-bg-1 { background: linear-gradient(90deg, #ecf3ff 80%, #e5eaf5 100%); }\n.drugguide-bg-2 { background: linear-gradient(90deg, #e8f4f2 85%, #e1eff4 100%); }\n.drugguide-bg-3 { background: linear-gradient(90deg, #fffde8 80%, #eaf3df 100%); }\n.drugguide-bg-4 { background: linear-gradient(90deg, #f7e7ec 80%, #ffe9e4 100%); }\n.drugguide-bg-5 { background: linear-gradient(90deg, #e4f0fa 80%, #eef7fc 100%); }\n.drugguide-bg-6 { background: linear-gradient(90deg, #f8eefe 68%, #dbeefd 100%); }\n.drugguide-bg-7 { background: linear-gradient(90deg, #fffbee 65%, #f9ece7 100%); }\n.drugguide-bg-8 { background: linear-gradient(90deg, #f6f8fa 74%, #ecf3ff 100%); }\n.drugguide-bg-9 { background: linear-gradient(90deg, #efefec 75%, #dee4e0 99%); }\n.drugguide-bg-conclu { background: linear-gradient(90deg, #f7f5fa 60%, #deeffb 100%); }\n.drugguide-bg-ref { background: linear-gradient(90deg, #f3f4f8 70%, #f6f2ea 100%); }\n.drugguide-content {\n  padding: 18px 28px 12px 32px;\n  font-size: 1.07em;\n  line-height: 1.85;\n}\n.drugguide-tip {\n  background: #e3eefd;\n  margin: 18px 0 0 0;\n  padding: 12px 16px;\n  border-left: 4px solid #5791e3;\n  border-radius: 7px;\n  color: #305889;\n  font-size: 1em;\n  box-shadow: 0 1px 5px rgba(120,160,180,0.05);\n  display: flex;\n  align-items: baseline;\n  gap: 10px;\n}\n.drugguide-badge {\n  display: inline-block;\n  background: #5791e3;\n  color: #fff;\n  border-radius: 5px;\n  font-size: 0.90em;\n  font-weight: 700;\n  padding: 2px 9px;\n  margin-right: 8px;\n  letter-spacing: 0.5px;\n}\nul.drugguide-ref-list {\n  margin: 0.6em 0 0.5em 2em;\n  padding: 0;\n  color: #345079;\n  font-size: 1em;\n  line-height: 1.8;\n  list-style: disc inside;\n}\n@media (max-width:640px) {\n  .drugguide-container { padding: 9px 2.5vw 20px 2.5vw; border-radius: 10px; }\n  .drugguide-title { font-size: 1.2em; border-radius: 6px;}\n  h2.drugguide-subtitle { padding-left: 13px; border-left-width: 4px; font-size: 1em;}\n  .drugguide-content { padding: 10px 5vw 8px 5vw; font-size: 1em;}\n  .drugguide-tip { font-size:0.98em;}\n}\n\u003C/style>\n","\u003C!-- 胰腺肿瘤化疗用药安全指南 HTML组件输出 -->\n\u003Cdiv class=\"drugguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"dr",559,"2025-07-18 11:33:23","吉西他滨, 替吉奥, 化疗药物, 实体瘤治疗, 药物相互作用, 不良反应, 用药安全, 超过剂量处理","掌握吉西他滨与替吉奥的使用细节，确保化疗安全。了解这两种药物的适应症、服用方法及潜在副作用，助你高效应对肿瘤治疗。","2025-07-21 11:54:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]